Skip to main content
Journal cover image

Erratum to "Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon S-S, Kavanagh D, Haller H; on behalf of the 311 Study Group. The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment" Kidney Int. 2020;97:1287-1296.

Publication ,  Journal Article
Rondeau, E; Scully, M; Ariceta, G; Barbour, T; Cataland, S; Heyne, N; Miyakawa, Y; Ortiz, S; Swenson, E; Vallee, M; Yoon, S-S; Kavanagh, D ...
Published in: Kidney Int
December 2020

Duke Scholars

Published In

Kidney Int

DOI

EISSN

1523-1755

Publication Date

December 2020

Volume

98

Issue

6

Start / End Page

1621

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Journal cover image

Published In

Kidney Int

DOI

EISSN

1523-1755

Publication Date

December 2020

Volume

98

Issue

6

Start / End Page

1621

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • 3202 Clinical sciences
  • 1103 Clinical Sciences